SEC
RDY icon

Seven Eight Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

Seven Eight Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-20,575
Closed -$275K – 799
2023
Q3 		$275K Buy
+20,575
New +$278K 0.03% 510

Other funds holding RDY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

Seven Eight Capital's RDY Position: Q4 2023 in Review

Seven Eight Capital sold out of Dr. Reddy's Laboratories (RDY) in Q4 2023, closing a stake of 20,575 shares — an estimated $275K sold.

Seven Eight Capital first reported a position in RDY in Q3 2023 and held it in 1 quarter. The position peaked at $275K in Q3 2023. 224 funds tracked by Wall St. Rank hold RDY as of Q4 2023.

  • Seven Eight Capital reported no remaining Dr. Reddy's Laboratories position as of Q4 2023 after selling out during the quarter.
  • Seven Eight Capital sold 20,575 Dr. Reddy's Laboratories shares in Q4 2023, an estimated $275K.
  • Seven Eight Capital first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 1 quarter.
  • Seven Eight Capital's Dr. Reddy's Laboratories position peaked at $275K in Q3 2023.
  • 224 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2023.

Based on Seven Eight Capital's 13F filing for Q4 2023, filed 13 Feb 2024.